ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scalp formula shows promise for hair regrowth in small study
Disease control CompletedThis study tested a special mineral-ionic formula called THERAVEX REGENERA in 20 adults with hair loss. The treatment was used during hair transplant procedures and as a scalp therapy to help hair follicles grow back. Researchers checked safety and measured changes in hair densit…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Biointelligent Technology Systems SL • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Hair loss breakthrough? new Under-the-Tongue pill tested in 142 men
Disease control CompletedThis study tested a new way to take minoxidil for male pattern baldness: a tablet placed under the tongue. 142 men with moderate to severe hair loss took either the minoxidil tablet or a placebo twice daily for 24 weeks. The goal was to see if this method increases hair count and…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Samson Clinical Operations Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hair loss gel enters human safety testing
Disease control CompletedThis early-stage trial tested the safety of a new topical gel called AH-001 in 64 healthy volunteers and men with male pattern baldness. Participants received either a single dose or daily doses for a week of the gel or a placebo. The study focused on side effects and how the dru…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1 • Sponsor: AnHorn Medicines Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New gel shows promise for thinning hair in early trial
Disease control CompletedThis study tested a gel called PP405 for male and female pattern baldness. 78 adults used the gel or a placebo for 28 days, then everyone could use the real gel for 3 more months. The main goals were to check safety and how the body processes the drug.
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE2 • Sponsor: Pelage Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Hair transplant healing boost? study tests antiseptic combo
Disease control CompletedThis study tested whether adding the antibiotic rifampicin to the standard antiseptic povidone-iodine could improve wound healing and prevent infection after hair transplantation. 65 adults were randomly assigned to receive either the combination or the standard antiseptic alone.…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Elif Asena KANTARCI • Aim: Disease control
Last updated Jun 26, 2026 14:10 UTC
-
Can a shampoo stop hair loss? new study says maybe
Symptom relief CompletedThis study tested a special shampoo for people with hair loss from telogen effluvium or early male/female pattern baldness. 40 adults used the shampoo for 3 months. The goal was to see if it improved hair length and thickness. The study is now complete.
Matched conditions: ANDROGENETIC ALOPECIA
Sponsor: Lacer S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC